Search results for "Glycogen"

showing 10 items of 189 documents

Optimal diet composition for European whitefish (Coregonus lavaretus): carbohydrate stress and immune parameter responses

2003

Abstract A feeding trial was conducted on the European whitefish to study the effects of replacing fish meal with fish oil and corn starch on the stress response and immune system parameters. Nine diets with varying levels of fish meal (FM; 38–86%), fish oil (FO; 2–22%) and corn starch (CS; 0–33%), and fixed levels of wheat meal (10%) and vitamin–mineral premix (2%) were formulated and replicates were allocated among 25 tanks following the D-optimality criteria. Fish were fed the extruded diets to satiation for 10 weeks in a flow-through freshwater system at 15 °C. The liver and plasma were sampled at the termination of the trial, and the response surfaces were modeled as Scheffe polynomial…

Vitaminmedicine.medical_specialtyMealGlycogenAquatic ScienceCarbohydrateBiologyFish oilchemistry.chemical_compoundFish mealEndocrinologyAnimal sciencechemistryInternal medicinemedicineComposition (visual arts)Corn oilAquaculture
researchProduct

Enhanced fermentative capacity of yeasts engineered in storage carbohydrate metabolism.

2014

During yeast biomass production, cells are grown through several batch and fed-batch cultures on molasses. This industrial process produces several types of stresses along the process, including thermic, osmotic, starvation, and oxidative stress. It has been shown that Saccharomyces cerevisiae strains with enhanced stress resistance present enhanced fermentative capacity of yeast biomass produced. On the other hand, storage carbohydrates have been related to several types of stress resistance in S. cerevisiae. Here we have engineered industrial strains in storage carbohydrate metabolism by overexpressing the GSY2 gene, that encodes the glycogen synthase enzyme, and deleting NTH1 gene, that …

biologySaccharomyces cerevisiaefood and beveragesBiomassTrehaloseSaccharomyces cerevisiaeCarbohydrate metabolismbiology.organism_classificationTrehaloseYeastchemistry.chemical_compoundIndustrial MicrobiologyBiochemistrychemistryMetabolic EngineeringFermentationbiology.proteinCarbohydrate MetabolismFermentationBiomassTrehalaseGlycogen synthaseGlycogenBiotechnologyBiotechnology progress
researchProduct

GSK-3 as potential target for therapeutic intervention in cancer

2014

// James A. McCubrey 1 , Linda S. Steelman 1 , Fred E. Bertrand 2 , Nicole M. Davis 1 , Melissa Sokolosky 1 , Steve L. Abrams 1 , Giuseppe Montalto 3 , Antonino B. D’Assoro 4 , Massimo Libra 5 , Ferdinando Nicoletti 5 , Roberta Maestro 6 , Jorg Basecke 7,8 , Dariusz Rakus 9 , Agnieszka Gizak 9 Zoya Demidenko 10 , Lucio Cocco 11 , Alberto M. Martelli 11 and Melchiorre Cervello 12 1 Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University Greenville, NC, USA 2 Department of Oncology, Brody School of Medicine at East Carolina University Greenville, NC, USA 3 Biomedical Department of Internal Medicine and Specialties, University of Palermo, Palermo, Italy …

cancer stem cellsNotchmedicine.medical_treatmentReviewmacromolecular substancesPI3KTargeted therapyGlycogen Synthase Kinase 3GSK-3Cancer stem cellNeoplasmsmedicinePTENAnimalsHumansRapamycinProtein kinase BPI3K/AKT/mTOR pathwayGSK-3; cancer stem cells; Wnt/beta-catenin; PI3K; Akt; mTOR; Hedgehog; Notch; Targeted Therapy; Therapy Resistance; Mutations RapamycinGSK-3Roswell Park Cancer InstitutebiologyAkt; Cancer stem cells; GSK-3; Hedgehog; MTOR; Mutations; Notch; PI3K; Rapamycin; Targeted therapy; Therapy resistance; Wnt/beta-cateninAnimalAktWnt/beta-cateninCancerTargeted TherapyTherapy Resistancemedicine.disease3. Good healthOncologybiology.proteinCancer researchmTORHedgehogMutationsHuman
researchProduct

Regulatory features of glycogen phosphorylase from frog brain (Rana temporaria)

1985

1. Glycogen content and the activity of glycogen phosphorylase (GPase) are much higher in brain tissue of the Common frog (Rana temporaria) than in brain tissue of mammals and birds (Table 1). 2. In phosphate buffer GPase is extracted from frog orain in a form completely active without addition of AMP and has therefore to be regarded as phosphorylase a. Several procedures to extract the b-form of the enzyme from the tissue have been unsuccessful. In resting skeletal muscle predominantly the AMP dependent b-form is present (Table 1). 3. In vitro, however, the existence of the complete interconverting system can be demonstrated. If NaF (a phosphatase inhibitor) was omitted from the homogeniza…

chemistry.chemical_classificationGlycogenPhysiologySkeletal muscleMetabolismBiologyBiochemistryGlycogen phosphorylasechemistry.chemical_compoundEndocrinologymedicine.anatomical_structureEnzymechemistryBiochemistrymedicineGRENOUILLEAnimal Science and ZoologyProtein phosphorylationEcology Evolution Behavior and SystematicsHomogenization (biology)Journal of Comparative Physiology B
researchProduct

(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channe…

2021

Multitarget-directed ligands (MTDLs) are considered a promising therapeutic strategy to address the multifactorial nature of Alzheimer's disease (AD). Novel MTDLs have been designed as inhibitors of human acetylcholinesterases/butyrylcholinesterases, monoamine oxidase A/B, and glycogen synthase kinase 3β and as calcium channel antagonists via the Biginelli multicomponent reaction. Among these MTDLs, (±)-BIGI-3h was identified as a promising new hit compound showing in vitro balanced activities toward the aforementioned recognized AD targets. Additional in vitro studies demonstrated antioxidant effects and brain penetration, along with the ability to inhibit the aggregation of both τ protein…

cholinesterasePhysiologyMonoamine oxidaseCognitive NeuroscienceLigandPharmacologyLigandsCalcium ChannelBiochemistry03 medical and health sciences0302 clinical medicineAlzheimer DiseaseIn vivoGSK-3HumansCholinesterasesCholinesterase InhibitorBiginelli reactionAlzheimer's disease; Biginelli reaction; calcium channel; cholinesterases; GSK 3β; MAO; Calcium Channel Blockers; Calcium Channels; Cholinesterase Inhibitors; Glycogen Synthase Kinase 3 beta; Humans; Ligands; Monoamine Oxidase; Alzheimer DiseaseMonoamine OxidaseGSK3B030304 developmental biologyCholinesterase0303 health sciencesGlycogen Synthase Kinase 3 betaVoltage-dependent calcium channelbiologyChemistryCalcium channelCell BiologyGeneral MedicineAlzheimer's diseaseCalcium Channel BlockersCalcium channel GSK 3β MAOMAObiology.proteinCalcium ChannelsCholinesterase InhibitorsGSK 3βMonoamine oxidase ACalcium Channel BlockerAlzheimer’s disease030217 neurology & neurosurgeryHuman
researchProduct

Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany

2015

Enzyme replacement therapy (ERT) has been shown to improve outcome in classical infantile Pompe disease. The purpose of this study was to assess mortality, morbidity, and shortcomings of ERT in a larger cohort of patients treated outside clinical trials. To accomplish this, we retrospectively analyzed the data of all 23 subjects with classical infantile Pompe disease having started ERT in Germany between January 2003 and December 2010.Ten patients (43%) deceased and four others (17%) became ventilator dependent. Seven infants (30.5%) made no motor progress at all, while seven (30.5%) achieved free sitting, and nine (39%) gained free walking. Besides all the seven patients (100%) attaining n…

congenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtybusiness.industryMEDLINEnutritional and metabolic diseases610 Medicine & healthDiseaseMetabolic myopathyEnzyme replacement therapymedicine.disease1301 Biochemistry Genetics and Molecular Biology (miscellaneous)ArticleClinical trial2712 Endocrinology Diabetes and Metabolism10036 Medical Clinic2724 Internal MedicineCohortmedicineGlycogen storage diseasebusiness
researchProduct

1-{3-[(7-Fluoro-9H-pyrimido[4,5-b]indol-4-yl)(methyl)amino]piperidin-1-yl}propan-1-one

2021

The title compound, C19H22FN5O, has been synthesized as an inhibitor of glycogen synthase kinase-3β. Two molecules interact via two N—H...N hydrogen bonds, forming centrosymmetric dimers.

crystal structurepyrimidoindoleCrystallographybiologykinase inhibitorStereochemistryHydrogen bondMeth-Crystal structurechemistry.chemical_compoundchemistryQD901-999biology.proteinGlycogen synthaseIUCrData
researchProduct

Reproductive Physiology ofAedes(Aedimorphus)vexans(Diptera: Culicidae) in Relation to Flight Potential

2001

Total protein, lipid, and glycogen of Aedes vexans (Meigen) were related linearly to body size at eclosion. Starvation after emergence led to the determination of minimal irreducible amounts of protein, lipid, and glycogen and the availability of the teneral reserves, whereas access to sucrose revealed the potential for reserve synthesis. Glycogenesis and lipogenesis increased reserves approximately 10-fold the teneral value within 1 and 2 wk after emergence, respectively. Carbohydrate feeding was an essential behavior before blood feeding and oogenesis commenced. Female flight was tested on a flight mill. Maximal flights of 10-17 km in a single night occurred at 2 wk posteclosion and paral…

food.ingredient1109 Insect Science3400 General Veterinary2405 Parasitology610 Medicine & healthBiology142-005 142-005chemistry.chemical_compoundfoodAnimal scienceAedesYolk600 TechnologyAnimalsAedes vexansAedesGeneral VeterinaryGlycogenEcologyReproduction2725 Infectious Diseasesbiology.organism_classificationBlood mealFecundityBlood proteinsInfectious DiseaseschemistryGlycogenesisInsect ScienceFlight Animal570 Life sciences; biologyParasitologyFemale
researchProduct

Disturbances in cholesterol, bile acid and glucose metabolism in peroxisomal 3-ketoacylCoA thiolase B deficient mice fed diets containing high or low…

2014

SPE IPM UB; International audience; : The peroxisomal 3-ketoacyl-CoA thiolase B (ThB) catalyzes the thiolytic cleavage of straight chain 3-ketoacyl-CoAs. Up to now, the ability of ThB to interfere with lipid metabolism was studied in mice fed a routinely laboratory chow enriched or not with the synthetic agonist Wy14,643, a pharmacological activator of the nuclear hormone receptor PPARα. The aim of the present study was therefore to determine whether ThB could play a role in obesity and lipid metabolism when mice are chronically fed a synthetic High Fat Diet (HFD) or a Low Fat Diet (LFD) as a control diet. To investigate this possibility, wild-type (WT) mice and mice deficient for Thb (Thb(…

lathosterol.medicine.medical_specialtymedicine.drug_classLathosterolCarbohydrate metabolismBiologyCholesterol 7 alpha-hydroxylaseDiet High-FatBiochemistrylathosterolBile Acids and Saltschemistry.chemical_compoundMiceInternal medicineIntestine Smallmedicine[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyAnimals[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyInsulin-Like Growth Factor I[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular Biology2. Zero hunger[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismbile acidsBile acidFatty acid metabolismCholesterolCholesterol HDLfood and beveragesLipid metabolismGeneral Medicine[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismAcetyl-CoA C-AcyltransferaseDietary FatsLiver GlycogenEndocrinologyCholesterolGlucosehypoglycemiade novo biosynthesis of cholesterolchemistryGrowth HormoneACOX1lipids (amino acids peptides and proteins)peroxisomal 3-ketoacyl-CoA thiolase B
researchProduct

Pathophysiology of Cerebral Ischemia

1991

The weight of the brain amounts to only 2% of total body weight, but it receives 15% of the cardiac output and uses 20% of the oxygen consumed by the body. The energy supply is provided almost exclusively by glucose metabolism. The substrate for this is stored in the brain in the form of glucose or glycogen and is sufficient to cover the energy requirements for only about 1 min. Consequently, there is a delicate equilibrium between oxygen and nutrient supply from the blood and the energy requirements of the brain. Disturbances in neurologic function appear after a few seconds of ischemia, although they are not necessarily persistent at first.

medicine.medical_specialtyCardiac outputGlycogenChemistryIschemiachemistry.chemical_elementCarbohydrate metabolismmedicine.diseaseOxygenCerebral edemachemistry.chemical_compoundEndocrinologyCerebral blood flowInternal medicinemedicineCerebral perfusion pressure
researchProduct